about
Genetic, household and spatial clustering of leprosy on an island in Indonesia: a population-based study.Relationship between HLA-DR gene polymorphisms and outcomes of hepatitis B viral infections: a meta-analysisPathways to gene identification in rheumatoid arthritis: PTPN22 and beyondThe neurodevelopmental impact of prenatal infections at different times of pregnancy: the earlier the worse?Screen for ISG15-crossreactive deubiquitinases.Parallels between pathogens and gluten peptides in celiac sprueHLA-A, HLA-B, HLA-DRB1 allele and haplotype frequencies in 6384 umbilical cord blood units and transplantation matching and engraftment statistics in the Zhejiang cord blood bank of China.On the genetic interpretation of disease dataFamilial analysis of seropositivity to Trypanosoma cruzi and of clinical forms of Chagas disease.The effect of heterogeneity on invasion in spatial epidemics: from theory to experimental evidence in a model systemStrategies to work with HLA data in human populations for histocompatibility, clinical transplantation, epidemiology and population genetics: HLA-NET methodological recommendationsEpidemiological and genetic correlates of severe acute respiratory syndrome coronavirus infection in the hospital with the highest nosocomial infection rate in Taiwan in 2003.Genetic resistance to Brucella abortus in the water buffalo (Bubalus bubalis).Single gene effects in mouse models of host: pathogen interactions.High interleukin-4 expression and interleukin-4 gene polymorphisms are associated with susceptibility to human paracoccidioidomycosis.The immune response to herpes simplex virus type 1 infection in susceptible mice is a major cause of central nervous system pathology resulting in fatal encephalitis.Natural selection and infectious disease in human populations.Progress and new directions in genetics of tuberculosis: an NHLBI working group report.Carriers of recessive WNK1/HSN2 mutations for hereditary sensory and autonomic neuropathy type 2 (HSAN2) are more sensitive to thermal stimuli.Immunity and immunopathology to viruses: what decides the outcome?From vaccine practice to vaccine science: the contribution of human immunology to the prevention of infectious disease.Implications of host genetic variation on the risk and prevalence of infectious diseases transmitted through the environment.Shared evolutionary origin of MHC polymorphism in sympatric lemurs.Polymorphisms in genes involved in folate metabolism as risk factors for oedematous severe childhood malnutrition: a hypothesis-generating study.Glutathione S-transferase polymorphisms may be associated with risk of oedematous severe childhood malnutrition.Unexpected high frequency of P46L TNFRSF1A allele in sub-Saharan West African populations.Microsatellites and Alu elements from the human MHC in Valencia (Spain): analysis of genetic relationships and linkage disequilibrium.Periodontal disease: a potential modifiable risk factor limiting conception.Antagonistic effects of a Mhc class I allele on malaria-infected house sparrows.Host-parasite interactions for virulence and resistance in a malaria model system.Role of genetic heterogeneity in determining the epidemiological severity of H1N1 influenza.Human Genomic Loci Important in Common Infectious Diseases: Role of High-Throughput Sequencing and Genome-Wide Association Studies.Plasmodium relictum infection and MHC diversity in the house sparrow (Passer domesticus).Endogenous versus exogenous fatty acid availability affects lysosomal acidity and MHC class II expression
P2860
Q24813908-6869B82C-55D5-44C6-8102-0D5398786B19Q26995535-3FD02BD5-1128-4C84-A2ED-AD06731ECE35Q28241686-0225FA98-D18E-46D1-BAA8-D3537713D852Q28303485-07B9793A-8D06-4953-859F-DED0E2D92BE6Q33291767-7A17B36F-77AB-40EA-AD7B-8C91F02BE941Q33329537-4E8D13AD-3940-461F-A354-9C390A704C01Q33455711-7F9AAEE8-4D4E-44C9-ACBD-6AF47F4864ECQ33529084-264025BF-CCDB-460A-985F-C24B628BAA48Q33578816-8BD5B9C2-1E00-4288-8F1E-3D947C18961DQ34042610-5D26A2F1-56FB-412C-940E-14866B92E749Q34245542-B4AA8A9C-A74D-41DA-B675-F3D566A6787EQ34430859-9EE7AE16-082D-4C83-BD61-9226940E57AAQ34492716-18552A83-8371-4893-B959-840C10BCED58Q36011351-64DA2AEB-EF3B-480F-84D8-008D7B013C5DQ36341255-7F7886DA-18C3-4FD5-A369-38C85E9FD930Q36747754-7B0A8AF5-805D-4034-A119-79A049929968Q37016206-37458479-D2CD-4072-B9AF-0303F8C1DEE4Q37282737-6C00BAFE-F5D3-4BD0-A6C9-D11D93E06BC5Q37359203-967B5145-7840-4E13-A8DC-FEB81903C111Q37767587-02E56071-4A0C-41CD-947F-AF3CE5F86AF0Q37837477-ACEC49B7-4DAA-485E-8B24-051B7D7B7138Q38526787-37FA0D6C-02D8-4A19-81FF-84C33B9AC6A2Q38612011-0B705122-2265-4D3E-8F41-AAC7FD000A2DQ39217743-1410D074-6626-4372-A4F3-06F6EB3D9A63Q39217750-D743B782-6C05-40E3-B9D6-D2139B5F3A16Q40519469-A3B0F6C4-3464-42CD-A645-F0088EC620D1Q43828860-F05C6E14-6270-4E90-BB21-1D52A876018EQ43865924-DA0A2D2F-AD96-48DE-86D8-1E1CA7BB701EQ47851351-2D2C456D-15D0-49C9-94BD-AA13C52DAAFEQ48034270-E0FAA0EA-5A6E-4CB8-AA8E-79CCE7B99711Q51783294-BF6454F8-6F83-4831-8A57-9D31956ED15FQ55261239-A41B7E14-ED6F-492C-86ED-89E3BF3596F2Q55554213-74D7EDB0-39AE-4832-A657-EB884986897CQ57375107-0517D375-1F20-493A-B4B0-E883E316FA6E
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Genetic susceptibility to infectious disease.
@ast
Genetic susceptibility to infectious disease.
@en
type
label
Genetic susceptibility to infectious disease.
@ast
Genetic susceptibility to infectious disease.
@en
prefLabel
Genetic susceptibility to infectious disease.
@ast
Genetic susceptibility to infectious disease.
@en
P1476
Genetic susceptibility to infectious disease.
@en
P2093
Shelley Segal
P304
P356
10.1016/S0966-842X(03)00207-5
P577
2003-09-01T00:00:00Z